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ABSTRACT
Background: Laparoscopic splenectomy of normal-sized
spleens or in moderate splenomegaly is performed with
increasing frequency. By using a modification of the open
laparotomy, minimal-access splenectomy is an attractive
alternative in severe splenomegaly.
Methods: Between September 2002 and October 2003, 9
patients (mean age, 58.8 years; range, 41 to 72) with
severe splenomegaly (mean length, 27.9 cm; range, 23 to
32) underwent minimal-access splenectomy. Indications
for splenectomy were non-Hodgkin’s lymphoma in 5
cases and idiopathic myelofibrosis in 4.
Results: Minimal-access splenectomy was successfully
completed in all patients. Mean operative time was 124
minutes (range, 75 to 165). Postoperative complications
occurred in 2 cases; one perioperative death occurred in a
patient with idiopathic myelofibrosis as a consequence of
a secondary blast crisis. Median postoperative hospital
stay was 9.1 days (range, 6 to 15).
Conclusions: Minimal-access splenectomy seems to be a
viable alternative to laparoscopic splenectomy in cases of
severe splenomegaly. It combines the advantages of hand
assistance like shorter operative times and increased
safety of the procedure to the classical benefits of mini-
mally invasive surgery.
Key Words: Minimally invasive surgery, Minimal access,
Laparoscopic splenectomy, Massive splenomegaly.
INTRODUCTION
The laparoscopic extirpation of normal-sized spleens has
become more common in the last few years. Since the first
attempts less than a decade ago,1,2 several reports have
described the challenges associated with this type of sur-
gery.3–5
Contraindications to a laparoscopic approach include se-
vere portal hypertension, uncorrectable coagulopathy, se-
vere ascites, and most traumatic injuries to the spleen.
Extreme splenomegaly remains a relative contraindication
as well.
Ultrasonography is performed to determine the size of the
spleen. Spleen size is expressed in terms of the maximum
interpole length and is generally classified into 3 catego-
ries: normal spleen size (11 cm); moderate splenomeg-
aly (11 cm to 20 cm); and severe or massive splenomegaly
(20 cm).6
Extremely large spleens present special technical prob-
lems that test the current limits of laparoscopic surgery.
However, as laparoscopic techniques, surgical skills, and
instrumentation have improved, so have the safety and
efficacy of this procedure even in the presence of spleno-
megaly.7–10 We consider all patients with massive spleno-
megaly as potential candidates for laparoscopic splenec-
tomy. Since June 1997, 82 laparoscopic splenectomies
have been performed for hematologic pathologies includ-
ing malignancies. All patients having massive splenomeg-
aly were treated by laparoscopy. Starting in September
2003, we attempted a new approach in cases of severe
splenomegaly.
We report a technique of splenectomy through minimal
access. The purpose of the study was to examine the
safety and efficacy of minimal-access splenectomy (MAS)
in the setting of massive splenomegaly.
METHODS
Patients
Between September 2002 and October 2003, 9 patients
were identified as having massive splenomegaly poten-
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SCIENTIFIC PAPERtially treatable through a minimal access approach. Patient
and disease characteristics are summarized in Table 1. Six
male and 3 female patients underwent MAS for the fol-
lowing disorders: non-Hodgkin’s lymphoma in 5 cases
and idiopathic myelofibrosis in 4. Mean age and BMI
(Body Mass Index) of the patients were respectively 58.8
years (range, 41 to 72) and 24.3 (range, 21.4 to 26).
Preoperative ultrasonography performed to determine the
size of the spleen showed a median interpole length of
27.9 cm (range, 23 to 32). The indications for splenectomy
included persistent thrombocytopenia and anemia due to
hypersplenism, as well as continuous steroid medication.
The subjective symptoms of all the patients included ab-
dominal distension and fullness, difficulty in lying on the
left side and left-sided upper quadrant pain.
Four patients affected by non-Hodgkin’s lymphoma had
chemotherapy before surgery. Preoperatively, the patients
were categorized as American Association of Anesthesiol-
ogy (ASA) class II (5 patients) and class III (4 patients).
The preoperative hemoglobin count averaged 10 g/L
(range, 7.8 to 15.4). Two patients required transfusion
before surgery.
Only 1 patient had a normal platelet count; the others had
thrombocytopenia, with an average count of 65 400/mm
3
(range, 8000 to 140 000/mm
3). Three of the patients re-
ceived a thrombocyte infusion immediately before the
operation.
Surgical Technique
The patients were placed in the supine decubitus position
with a sandbag under the left flank. A left 14-cm incision
was made under the costal margin. The operation was
conducted under direct vision. Field exposure was
achieved by conventional abdominal wall retractors. The
Ultrasonic dissector was the only laparoscopic instrument
necessary for the operation. Optional laparoscopic tools
consisted of a clip applier and a vascular stapler.
First, the stomach was retracted medially to expose the
spleen. A thorough search was then made for accessory
spleens. Any accessory spleens found were removed im-
mediately. An incision was carried slightly into the left
side of the gastrocolic ligament. This step afforded access
to the gastrosplenic ligament and the opening of the lesser
sac in its lateral portion.
Next, the short gastric vessels were divided by using the
Ultrasonic dissector or eventually over clips (Figure 1).
The uppermost vessels of the gastrosplenic ligament are
very short and enlarged in splenomegaly, and they are
located in the immediate vicinity of the diaphragm. Access
to these vessels required combined dislocation of the
stomach to the right and gentle retraction of the upper
splenic pole to the left.
Then the dissection reached the hilum and the vessels
could be isolated from the pancreas and the surrounding
tissues by combining a careful digital dissection with the
use of the Ultrasonic dissector.
If a distributed anatomy was present, the splenic branches
were usually dissected and divided between silk ligatures
or clipped. In case of magistral anatomy, after providing
that the tail of the pancreas is identified and dissected
away, we performed separate silk ligation of the splenic
vessels with a delayed ligature of the vein, to achieve a
volumetric reduction of the spleen.
Table 1.
Patient and Disease Characteristics
Characteristic Minimal-access Splenectomy N9
MeanSD; Range
Age, years 58.811; 41–72
Male:female 6:3
Body mass index 24.33.1; 21.4–26
Spleen size, cm 27.93.5; 23–32
Preoperative platelet count,
10
3/mm
3
108135; 8–457
Hematologic diagnosis non-Hodgkin’s Lymphoma: 5
idiopathic myelofibrosis: 4 Figure 1. Division of the short gastric vessels by using the
Ultrasonic dissection.
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ing the splenocolic ligament, the lower part of the phreni-
cocolic ligament, and the sustentaculum lienis. Finally, the
phrenicocolic ligament was incised all the way to the left
crus of the diaphragm by the Ultrasonic dissector. A sterile
organ-retrieval bag was used for the extraction of the
spleen. This bag was introduced into the abdominal cav-
ity, and the spleen was manually slipped inside to prevent
splenosis during the subsequent manipulations. Grasping
forceps were used to hold the edges of the bag and to
effect partial closure. At the end of the procedure, a
nasogastric tube and an abdominal drain in the left hypo-
chondrium were left in place.
RESULTS
Perioperative features are summarized in Table 2. The
operative time ranged from 75 minutes to 165 minutes
(mean, 124). Two accessory spleens were detected and
removed in 1 patient. The average weight of the spleen
was 2500 g (range, 1700 to 3200). The average intraoper-
ative blood loss was 572 mL (range, 150 to 1000). Five
patients received an average of 3U of packed red cells,
and 4 of the splenectomies were performed without such
a transfusion. In all patients, a nasogastric tube was left in
and removed on the first postoperative day. Oral intake
was assured from the second to the sixth postoperative
day (mean, 3). Postoperative complications occurred in 2
cases: one patient had pleural effusion and another pa-
tient developed pneumonia, which were treated medi-
cally. One perioperative death occurred 15 days after the
operation in a patient with idiopathic myelofibrosis as a
consequence of a secondary blast crisis.
Mean postoperative hospital stay was 9.1 days (range, 6 to
15). The average preoperative platelet count was 108
911/mm
3 (range, 8000 to 457 000). The average postop-
erative platelet count was 479 111/mm
3 (range, 6,000 to 1
262 000). The average improvement in platelet count at
discharge was 370 200/mm
3.
DISCUSSION
Massive splenectomy virtually always relates to hemato-
logical malignancies. In these patients, the local discom-
fort from massive splenomegaly and the risks of re-
fractable thrombocytopenia and anemia are conventional
indications for splenectomy.11,12 Open splenectomy has
been associated with substantial morbidity and mortality,
and the rates may be higher in patients with splenomeg-
aly, patients with myeloproliferative disorders, and the
elderly.13,14
We consider all patients with massive splenomegaly as
potential candidates for laparoscopic splenectomy, and
the laparoscopic approach has been used since June 1997.
Starting in September 2002, in cases of massive spleno-
megaly, we have adopted the MAS technique for 2 rea-
sons. First, in the laparoscopic approach, a service mini-
laparotomy is always performed when pathologic
examination of the surgical specimen is required to doc-
ument the hematological disease. Second, laparoscopic-
assisted removal of the entire spleen via an accessory
mini-laparotomy does not affect the duration of surgery,
rate of complications, or length of hospital stay.15,16
Concerning the technical aspects of the operation, Ultra-
sonic dissection is essential. Its use is advocated in every
step of the procedure: from the dissection of the spleno-
colic to the gastrosplenic ligament, from the dissection of
the hilar vessels to the spleno-diaphragmatic ligament.
The use of a clip applier or a vascular stapler was neces-
sary in only a few cases. Separate ligation of the hilar
vessels was performed whenever possible.
Once the lesser sac is opened, the next step is the iden-
tification and ligation of the splenic artery. We found that
the early ligation of this vessel is really advantageous.
Volumetric reduction of the spleen after this manoeuvre is
important, thus enabling the surgeon to perform the next
steps of the dissection more easily.
Manual handling succeeds in creating a working space
that would be difficult to achieve with the simple manip-
ulation of the laparoscopic instruments.
Furthermore, hand assistance, by regaining tactile feed-
back, also increases the safety of the procedure, because
it enables the surgeon to rapidly identify vascular struc-
tures and, in the case of accidental bleeding, allows im-
mediate hemostatic control by digital compression.
Table 2.
Perioperative Features of Patients Who Underwent
Minimal-Access Splenectomy (n9)
Factor MeanSD; Range
Operative time (min) 1248; 75–165
Estimated blood loss (mL) 572346; 150–1000
Oral resumption, (PO day) 31; 2–6
Length of stay, (days) 9.13.1; 6–15
Morbidity (n) 2 (22.22%)
Deaths (n) 1 (11.11%)
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served because dissection in the MAS technique tends to
identify and dissect away the tail of the pancreas. A severe
blast crisis not directly related to surgery was responsible
for the only perioperative death that occurred in a patient
affected by idiopathic myelofibrosis. Median length of
hospital stay for the rest of the patients was 7.5 days. In
regard to massive splenomegaly in malignancies, this
value is comparable to that reported in the literature and
to that of our historic patients treated with a fully laparo-
scopic approach.9,15,17,18
We believe that experience with laparoscopic splenec-
tomy is necessary to perform MAS; in fact, the laparo-
scopic skills of the surgeon greatly facilitate dissection
with this approach.
CONCLUSION
MAS in patients with severe splenomegaly represents a
viable option, because it is feasible and effective. The
main concern of this study is the limited number of pa-
tients. A larger series is needed to confirm the reported
results.
We found MAS to be an attractive alternative to laparos-
copy in cases of massive splenomegaly. It combines the
advantages of hand assistance, shorter operative times,
and increased safety of the procedure with the classical
benefits of minimally invasive surgery.
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